145 related articles for article (PubMed ID: 38401022)
1. Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study.
Hara K; Hirase T; Pathadka S; Cai Z; Sato M; Ishida N; Takemura R
Diabetes Ther; 2024 Apr; 15(4):801-817. PubMed ID: 38401022
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study.
Ishigaki Y; Hirase T; Pathadka S; Cai Z; Sato M; Takemura R; Ishida N
Diabetes Ther; 2024 Jan; 15(1):245-256. PubMed ID: 37856046
[TBL] [Abstract][Full Text] [Related]
3. Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012-2019.
Boye KS; Lage MJ; Shinde S; Thieu V; Bae JP
Diabetes Ther; 2021 Jul; 12(7):2077-2087. PubMed ID: 34076849
[TBL] [Abstract][Full Text] [Related]
4. The iHealth-T2D study, prevention of type 2 diabetes amongst South Asians with central obesity and prediabetes: study protocol for a randomised controlled trial.
Kasturiratne A; Khawaja KI; Ahmad S; Siddiqui S; Shahzad K; Athauda LK; Jayawardena R; Mahmood S; Muilwijk M; Batool T; Burney S; Glover M; Palaniswamy S; Bamunuarachchi V; Panda M; Madawanarachchi S; Rai B; Sattar I; Silva W; Waghdhare S; Jarvelin MR; Rannan-Eliya RP; Gage HM; van Valkengoed IGM; Valabhji J; Frost GS; Loh M; Wickremasinghe AR; Kooner JS; Katulanda P; Jha S; Chambers JC
Trials; 2021 Dec; 22(1):928. PubMed ID: 34922608
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effects of Metformin and Dipeptidyl Peptidase-4 Inhibitors in Japanese Obese Patients with Type 2 Diabetes: A Claims Database Study.
Odawara M; Aoi S; Takeshima T; Iwasaki K
Diabetes Ther; 2021 Aug; 12(8):2165-2177. PubMed ID: 34218420
[TBL] [Abstract][Full Text] [Related]
6. Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data.
Boye KS; Lage MJ; Thieu V; Shinde S; Dhamija S; Bae JP
J Diabetes Complications; 2021 Sep; 35(9):107975. PubMed ID: 34176723
[TBL] [Abstract][Full Text] [Related]
7. FAT-FREE MASS, METABOLICALLY HEALTHY OBESITY, AND TYPE 2 DIABETES IN SEVERELY OBESE ASIAN ADULTS.
Pramyothin P; Limpattanachart V; Dawilai S; Sarasak R; Sukaruttanawong C; Chaiyasoot K; Keawtanom S; Yamwong P
Endocr Pract; 2017 Aug; 23(8):915-922. PubMed ID: 28614006
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin A1c and Type 2 Diabetes Incidence Among Adolescents With Overweight and Obesity.
Hoe FM; Darbinian JA; Greenspan LC; Lo JC
JAMA Netw Open; 2024 Jan; 7(1):e2351322. PubMed ID: 38231515
[TBL] [Abstract][Full Text] [Related]
9. Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.
Newson RS; Divino V; Boye KS; Chen J; DeKoven M; Vallarino C; Ranta K; Mount JE
Diabetes Ther; 2024 Jun; 15(6):1435-1449. PubMed ID: 38683494
[TBL] [Abstract][Full Text] [Related]
10. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
[TBL] [Abstract][Full Text] [Related]
11. Team-based multicomponent care improved and sustained glycaemic control in obese people with type 2 diabetes (T2D) in a Diabetes Centre setting: A quality improvement program with quasi-experimental design.
Lim LL; Lau ESH; Ozaki R; So TTY; Wong RYM; Chow EYK; Ma RCW; Luk AOY; Chan JCN; Kong APS
Diabetes Res Clin Pract; 2022 Dec; 194():110138. PubMed ID: 36328212
[TBL] [Abstract][Full Text] [Related]
12. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
[TBL] [Abstract][Full Text] [Related]
13. MC4R rs17782313 gene polymorphism was associated with glycated hemoglobin independently of its effect on BMI in Japanese: the Shimane COHRE study.
Mutombo PB; Yamasaki M; Hamano T; Isomura M; Nabika T; Shiwaku K
Endocr Res; 2014; 39(3):115-9. PubMed ID: 24151814
[TBL] [Abstract][Full Text] [Related]
14. Optimal cut-points of different anthropometric indices and their joint effect in prediction of type 2 diabetes: results of a cohort study.
Zafari N; Lotfaliany M; Mansournia MA; Khalili D; Azizi F; Hadaegh F
BMC Public Health; 2018 Jun; 18(1):691. PubMed ID: 29866083
[TBL] [Abstract][Full Text] [Related]
15. HbA1c levels are associated with severity of hypoxemia and not with apnea hypopnea index in patients with type 2 diabetes: Results from a cross-sectional study.
Rusu A; Bala CG; Craciun AE; Roman G
J Diabetes; 2017 Jun; 9(6):555-561. PubMed ID: 27447735
[TBL] [Abstract][Full Text] [Related]
16. Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysis.
Hu S; Lin C; Cai X; Li Z; Lv F; Yang W; Ji L
EClinicalMedicine; 2023 Mar; 57():101868. PubMed ID: 36864984
[TBL] [Abstract][Full Text] [Related]
17. Glycemic outcomes in patients with type 2 diabetes after bariatric surgery compared with routine care: a population-based, real-world cohort study in the United Kingdom.
Singh P; Adderley NJ; Subramanian A; Gokhale K; Hazlehurst J; Singhal R; Bellary S; Tahrani AA; Nirantharakumar K
Surg Obes Relat Dis; 2022 Dec; 18(12):1366-1376. PubMed ID: 36123295
[TBL] [Abstract][Full Text] [Related]
18. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.
Jiang G; Luk AO; Tam CHT; Lau ES; Ozaki R; Chow EYK; Kong APS; Lim CKP; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung SKS; Cheng YL; Chow CC; Pearson ER; So WY; Chan JCN; Ma RCW; ;
PLoS Med; 2020 Jul; 17(7):e1003209. PubMed ID: 32722720
[TBL] [Abstract][Full Text] [Related]
19. Variation in the risk of progression between glycemic stages across different levels of body mass index: evidence from a United States electronic health records system.
Blume SW; Li Q; Huang JC; Hammer M; Graf TR
Curr Med Res Opin; 2015 Jan; 31(1):115-24. PubMed ID: 25266974
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic status and risk factors for complications in young people with type 1 or type 2 diabetes: a cross-sectional study.
Wijayaratna S; Lee A; Park HY; Jo E; Wu F; Bagg W; Cundy T
BMJ Open Diabetes Res Care; 2021 Dec; 9(2):. PubMed ID: 34969690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
